Healthcare

VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs

VSee Health AI telehealth technology leader highlights client success and growing market momentum in virtual care SAN JOSE, CALIFORNIA /…

3 weeks ago

A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity

SAN DIEGO, CA / ACCESS Newswire / December 4, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a…

3 weeks ago

VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs

VSee Health AI telehealth technology leader highlights client success and growing market momentum in virtual care SAN JOSE, CALIFORNIA /…

3 weeks ago

Black Book RSNA Flash Poll: 3 in 4 Imaging Leaders Have No Clear ROI for AI – Yet Adoption Marches On

Per-Study and Bundled Deals Dominate as Imaging AI Remains a Discretionary Spend CHICAGO, ILLINOIS / ACCESS Newswire / December 4,…

3 weeks ago

TriageLogic Expands Global Health Access in Emerging Markets With Core Clinical Decision Support

TriageLogic's scalable triage intelligence anchors a new model for community-level care in Africa and South America. JACKSONVILLE, FL / ACCESS…

3 weeks ago

Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay

Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN…

3 weeks ago

Parexel Showcases Industry-Leading Hematology Expertise with Presentation of 10 Research Posters at the American Society of Hematology (ASH) Annual Meeting

Scientific and medical presence at ASH underscores Parexel’s proven expertise at premier event for classical and malignant hematologyRALEIGH, N.C., Dec.…

3 weeks ago

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

AUSTIN, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent…

3 weeks ago

Medera to Participate in Oppenheimer Movers in Rare Disease Summit 2025

BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by…

3 weeks ago

Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop

MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

3 weeks ago